Stock overview
Arrowhead Pharmaceuticals Inc.
Explore the company, reported ownership, price history, and available source evidence.
ARROWHEAD PHARMACEUTICALS INC (ARWR) is a listed warrant, unit, right, or acquisition-company security tracked from 13F filings.
- Last close
- $43.11
- · ARWR
- Tracked holders
- 4 funds
- Latest available 13F per fund
ARWR · USD
Price
Close · Nov 18, 2026
- Range low
- $38.09
- Range high
- $89.59
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | −14% 26'Q3 | $111,857,519 | 0.53% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | −93% 26'Q3 | $2,225,300 | 0% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $690,890 | 0% |
| Gotham Asset Management position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +44% 26'Q3 | $629,629 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market